DNAtrix Presents Positive Results from the Phase 2 CAPTIVE/KEYNOTE-192 Study of DNX-2401 in Combination with Pembrolizumab for Glioblastoma at the 2019 SNO Annual Meeting

HOUSTON, Nov. 24, 2019 /PRNewswire/ — DNAtrix, a leader in the development of oncolytic viruses for cancer therapy, today presented updated safety and efficacy data from the fully-enrolled Phase 2 CAPTIVE / KEYNOTE-192 study of DNX-2401 (tasadenoturev), DNAtrix’s oncolytic adenovirus,…

from PR Newswire: https://ift.tt/2XG2wPk

Compare the Best Sony PS4 & PS VR Black Friday Deals 2019: Early PlayStation 4 Pro, Slim & PS VR Bundle Sales Reviewed by Spending Lab

BOSTON, Nov. 24, 2019 /PRNewswire/ — Searching for the top Sony PlayStation 4 and PlayStation VR deals for Black Friday 2019? Deal reviewers at Spending Lab have published their list of the best early PS4, PS4 Pro, PS4 Slim and PS VR deals for 2019. Find their updated list of links to…

from PR Newswire: https://ift.tt/2QNTCOk